| Date Filed | Type | Description |
| 09/24/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 09/22/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/22/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/16/2021 |
SC 13D/A
| Baupost Group reports a 0% stake in Translate Bio, Inc. |
| 09/14/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/14/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/14/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/14/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/14/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 09/14/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 09/14/2021 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 09/14/2021 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 09/14/2021 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 09/14/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 09/14/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/14/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/10/2021 |
SC 13G/A
| FMR LLC reports a 0.3% stake in TRANSLATE BIO INC |
| 09/07/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 08/27/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 08/27/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 08/16/2021 |
SC 13D
| Magnetar Financial LLC reports a 5.3% stake in Translate Bio, Inc. |
| 08/16/2021 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 08/16/2021 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 08/12/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/05/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 08/04/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/03/2021 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 08/03/2021 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 08/03/2021 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
| 06/16/2021 |
8-K
| Quarterly results |
| 05/18/2021 |
CT ORDER
| Form CT ORDER - Confidential treatment order: |
| 05/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/06/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 04/28/2021 |
GN
| Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit |
|